Candel Therapeutics partners with EVERSANA for drug commercialization

Go back to Candel Therapeutics partners with EVERSANA for drug commercialization
(NASDAQ: CADL) Delayed: 8.31 --0 (-0%)
Previous Close $8.31    52 Week High
Open $8.31    52 Week Low
Day High $8.31    P/E N/A 
Day Low $8.31    EPS
Volume 6,331